Diamondback Energy Inc vs Medtronic PLC — how do they compare? Diamondback Energy Inc trades at $190.9 (market cap $53.38B), while Medtronic PLC trades at $83.38 (market cap $103.01B). The key difference: Medtronic PLC is the larger of the two by market cap, and Medtronic PLC pays the higher dividend (3.58%). Which is the better fit depends on your goals.
| FANG | MDT | |
|---|---|---|
Market Cap | $53.38B | $103.01B |
Sector | Energy | Health |
52-Week High | $213.69 | $105.35 |
52-Week Low | $134.53 | $73.75 |
Enterprise Value | $67.11B | $121.75B |
Dividend Yield | 2.32% | 3.58% |
Signals from Pluang's Aura AI — not financial advice
Diamondback Energy (FANG) trades at $191.28, up 0.31% on the day, with a bullish technical signal and strong analyst support. Recent earnings show mixed results, beating estimates in Q1 2026 but missing in Q4 2025, while revenue growth remains robust. The company maintains solid cash flow from operations and a manageable debt-to-asset ratio of 22.26% as of 2025. A dividend of $1.10 was recently declared, with the next earnings report scheduled for August 3, 2026.
FANG presents a favorable outlook with a consensus price target of $234.50, implying 22.6% upside, supported by 90% buy ratings from analysts. Risks include volatile oil prices, geopolitical factors affecting energy markets, and declining net income margins. The stock's high P/E ratio of 193.63 warrants caution, but strong operational cash flow and institutional bullishness provide a solid foundation for growth-oriented investors.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Diamondback Energy is an independent oil and gas producer in the United States. The company operates exclusively in the Permian Basin. At the end of 2021, the company reported net proven reserves of 1.8 billion barrels of oil equivalent. Net production averaged about 375,000 barrels per day in 2021, at a ratio of 60% oil, 20% natural gas liquids, and 20% natural gas.
Read more on FANG →One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →